Top Biopharma Startups in United Kingdom (2025 Update)
Explore the best Biopharma companies in United Kingdom. Discover high-growth startups and investment opportunities in our 2025 updated list.
👋🏼 Hello! I'm Bounce Watch, collecting insights from Top Biopharma Startups in United Kingdom watchlist for you.
Real-Time Scouting Assistant
Explore Top Biopharma Startups in United Kingdom featuring 104 Companies
|
|
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
MAXWELLIA | - | We are the world’s only company dedicated to converting prescription medicines i... | Maxwellia is a pioneering British start-up pharma company building a pipeline of... | - |
United Kingdom
|
Alderley Edge | United Kingdom (HQ) + 1 | 2013 | Biopharma, Health Care +1 | [email protected] |
1
Low
|
11
|
20 (-100%) | 3 years ago | Series Unknown | 3 | 3.9M | 1624 | 5 months ago | |
|
|
|
MultiplAI Health | - | MultiplAI leverages genomics and AI to provide universal remote screening for ca... | MultiplAI Health is a preventive medicine company pioneering blood screening for... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2019 | AI, Biopharma +3 | [email protected] |
1
Low
|
14
|
49 | 2 years ago | Seed | 3 | 2.3M | 13329 | 10 months ago | |
|
|
|
PHARMASEAL | - | An Innovative Clinical Trial Management System for Unified Trial Governance used... | PHARMASEAL was founded in 2016 by a team of industry leaders who share a vision... | - |
United Kingdom
|
Nottingham | United Kingdom (HQ) | 2016 | Biopharma, Health Care +1 | [email protected] |
1
Low
|
11
|
19 (-100%) | 4 years ago | Equity Crowdfunding | 5 | 2.1M | 930 | 5 months ago | |
|
|
|
Bloomsbury Genetic Therap... | - | Dedicated to delivering the promise of gene therapy | Bloomsbury Genetic Therapies ("Bloomsbury") is a clinical-stage biotechnology co... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2021 | Biopharma, Biotechnology +1 | - |
1
Low
|
7
|
870 (42%) | 2 years ago | Seed | 1 | 5.0M | 1736 | 6 months ago | |
|
|
|
PredictImmune | - | PredictImmune creates lab tests to guide personalized treatment for immune-media... | PredictImmune is at the forefront of innovative tools for assessing tailored tre... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2017 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
108
|
483 (-10%) | 2 years ago | Grant | 6 | 31.4M | 81193 | 2 uWA Jql | |
|
|
|
Mereo BioPharma | - | Mereo BioPharma is a clinical-stage company focused on developing & commercialis... | Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused o... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2015 | Biopharma, Biotechnology +1 | - |
1
Low
|
45
|
3.1K (-21%) | 11 months ago | Post Ipo Equity | 6 | 387.5M | 4621 | 5 months ago | |
|
|
|
Autolus Therapeutics | - | Focused on the development of precisely targeted, controlled & highly active T c... | Autolus is a CAR T cell therapy company. We are applying our extensive programmi... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2014 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
664
|
21.0K (42%) | 1 year ago | Post Ipo Equity | 10 | 1.1B | 27400 | 6 months ago | |
|
|
|
Wren Therapeutics | - | Stopping the wave of neurodegeneration at its source | WaveBreak (www.WaveBreakTx.com) is a biopharmaceutical company focused transform... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2016 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
34
|
853 (-100%) | 4 years ago | Series Unknown | 3 | 30.4M | 2143 | 1 year ago | |
|
|
|
Lifelancer | - | Talent Hiring Platform in Life Sciences & Pharma | Lifelancer is an AI-powered platform for talent hiring in Life Sciences, Pharma,... | - |
United Kingdom
|
London | United Kingdom (HQ) + 2 | 2020 | AI, Biopharma +6 | [email protected] |
1
Low
|
11
|
13.6K (-36%) | 3 months ago | Pre Seed | 5 | 532.5K | 23769 | 5 months ago | |
|
|
|
Evonetix Ltd | - | Technology to ignite the biology revolution | We are a Cambridge-based company developing a radically different approach to ge... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2015 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
21
|
3.6K | 2 years ago | Series B | 4 | 68.1M | 5122 | 1 year ago | |
|
|
|
Caristo Diagnostics | - | Medical Device for Vascular Disease Diagnosis | Caristo Diagnostics has been formed to bring revolutionary cardiovascular diagno... | - |
United Kingdom
|
Oxford | United Kingdom (HQ) | 2017 | Biopharma, Health Care +1 | [email protected] |
1
Low
|
50
|
2.2K | 8 months ago | Series Unknown | 4 | 30.1M | 4798 | 3 months ago | |
|
|
|
Duke Street Bio | - | Pioneering Next Generation Cancer Therapies | Duke Street Bio is focused on exploiting tumour genetic vulnerabilities and harn... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
10
|
109 | 1 year ago | Seed | 4 | 5.1M | 636 | 6 months ago | |
|
|
|
Inspira Pharmaceuticals L... | - | UK biotech focused on preclinical research for diseases of the respiratory tract | UK biotech focused on preclinical research for diseases of the respiratory tract | - |
United Kingdom
|
London | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
4
|
334 (29%) | 4 years ago | Equity Crowdfunding | 1 | 377.2K | 366 | 1 year ago | |
|
|
|
ĹŚGI Bio | - | Offering our customers an affordable route into the automation of routine microb... | ĹŚGI Bio offers our customers in the microbiology sector an affordable route into... | - |
United Kingdom
|
Edinburgh | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology | [email protected] |
1
Low
|
11
|
791 | 11 months ago | Seed | 2 | 1.7M | 1072 | 5 months ago | |
|
|
|
Adendra Therapeutics | - | Translating dendritic cell biology into new therapies for cancer and autoimmunit... | Adendra is an emerging biotechnology company building on new insights into dendr... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2021 | Biopharma, Biotechnology +1 | - |
1
Low
|
2
|
796 | 3 years ago | Series A | 1 | 40.0M | 897 | 10 months ago | |
|
|
|
Artios | 3 weeks ago mentioned on Thenextweb. (View) | Taking control of the DNA Damage Response (DDR) | Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) an... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) + 1 | 2016 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
131
|
4.5K | 3 years ago | Series C | 5 | 298.3M | 10786 | 4 months ago | |
|
|
|
Healx | - | AI-powered and patient-inspired. We accelerate the discovery and development o... | Healx is a mission-driven technology company pioneering the next generation of d... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2014 | AI, Biopharma +3 | [email protected] |
1
Low
|
70
|
4.9K | 10 months ago | Series C | 7 | 114.9M | 18926 | 3 months ago | |
|
|
|
CN Bio | - | Generate human-specific efficacy and safety data with PhysioMimix® Single- and M... | CN Bio is a leading organ-on-a-chip (OOC) company that enables researchers to im... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2008 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
62
|
6.6K (6%) | 1 year ago | Series B | 6 | 44.5M | 7417 | 3 months ago | |
|
|
|
Tay Therapeutics Ltd | - | Bridging discovery to translation | Tay Therapeutics is a UK based drug discovery company. | - |
United Kingdom
|
Dundee | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology +1 | - |
1
Low
|
12
|
32 (-97%) | 3 years ago | Seed | 2 | 1.6M | 951 | 10 months ago | |
|
|
|
Axol Bioscience Ltd. | - | Better Human Disease Models | World leaders in iPSC technology supporting the next generation of advanced mode... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) + 1 | 2013 | Biopharma, Biotechnology | [email protected] |
1
Low
|
49
|
6.1K (-28%) | 3 years ago | Series Unknown | 4 | 10.5M | 9372 | 5 months ago | |
|
|
|
Samsara Therapeutics | - | Treating Neurodegenerative Disease by Restoring Autophagy | At Samsara Therapeutics, we’re on a mission to unlock the full potential of auto... | - |
United Kingdom
|
Oxford | United Kingdom (HQ) + 1 | 2018 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
19
|
1.8K (-14%) | 2 years ago | Series A | 5 | 13.5M | 2153 | 8 months ago | |
|
|
|
SolasCure | - | Transforming chronic wound care with a breakthrough wound therapeutic | Chronic wounds affect ~100m people around the world, impacting quality of life &... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2017 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
17
|
850 (-43%) | 1 year ago | Grant | 5 | 26.3M | 1441 | 5 months ago | |
|
|
|
F-star, an invoX company | - | A clinical-stage biopharma developing next gen bispecific antibodies to transfor... | F-star, an invoX company, is a clinical-stage biopharmaceutical business pioneer... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2006 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
42
|
1.9K (58%) | 4 years ago | Post Ipo Equity | 8 | 137.3M | 11313 | 1 year ago | |
|
|
|
Elastrin Therapeutics | - | Using drug-loaded nanoparticles for the effective treatment of life-threatening... | Elastrin Therapeutics is a UK and US-based biotech developing novel therapies to... | - |
United Kingdom
|
Oxford | United Kingdom (HQ) + 1 | 2017 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
8
|
660 (-40%) | 1 year ago | Series Unknown | 4 | 20.8M | 2367 | 1 year ago | |
|
|
|
HydRegen | - | We are passionate about enabling biotechnology for a more sustainable chemicals... | Our biotechnologies enable more sustainable chemical synthesis and manufacturing... | - |
United Kingdom
|
Oxford | United Kingdom (HQ) | 2020 | Biopharma, Biotechnology +1 | - |
1
Low
|
16
|
473 | 2 years ago | Seed | 2 | 2.6M | 1551 | 5 months ago | |
|
|
|
Spur Therapeutics | - | Toward the next generation of gene therapy. | Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechno... | - |
United Kingdom
|
Stevenage | United Kingdom (HQ) + 2 | 2015 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
122
|
2.4K (-8%) | 3 years ago | Post Ipo Equity | 7 | 302.1M | 11419 | 5 months ago | |
|
|
|
Concr | - | Solving data to enable precision therapy for all | Concr is a techbio company providing predictive modelling solutions to enhance c... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2018 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
13
|
1.6K (14%) | 1 year ago | Grant | 4 | 2.4M | 1064 | 5 months ago | |
|
|
|
FuturNet Communication | Not active anymore | La vision du futur |
CompanDx unlocks the secrets of personalised medicine. We exploit our in-house... |
- |
United Kingdom
|
Nottingham | United Kingdom (HQ) | 2008 | Biopharma, Biotechnology | - |
-1
N/A
|
1
|
48 | 12 years ago | Series Unknown | 1 | 3.9M | 72397 | 6 Bvq 3iM | |
|
|
|
Kinomica | - | A proteomic-data science and diagnostics company specialising in cell signalling... | Kinomica is a pioneering precision medicine research and diagnostics company spe... | - |
United Kingdom
|
Alderley Edge | United Kingdom (HQ) + 3 | 2016 | Biopharma, Biotechnology | [email protected] |
1
Low
|
26
|
675 (-100%) | 4 years ago | Series A | 2 | 3.9M | 2187 | 6 months ago | |
|
|
|
Arecor Therapeutics plc | - | Advancing today’s therapies to enable healthier lives | Arecor Therapeutics plc is a globally focused biopharmaceutical company transfor... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2007 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
37
|
121 (-100%) | 2 years ago | Post Ipo Equity | 11 | 26.6M | 3361 | 5 months ago | |
|
|
|
Biodexa Pharmaceuticals P... | - | Advancing Medicines for a Brighter Future | Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biophar... | - |
United Kingdom
|
Cardiff | United Kingdom (HQ) | 2000 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
23
|
1.3K | 10 months ago | Post Ipo Equity | 7 | 46.7M | 4210 | 6 months ago | |
|
|
|
Almac Group | - | A unique culture delivering exceptional solutions |
Partnering to Advance Human Health A unique culture delivering exceptional solu... |
- |
United Kingdom
|
Craigavon | United Kingdom (HQ) + 8 | 1968 | Biopharma, Biotechnology | - |
1
Low
|
4534
|
361 (-100%) | 6 years ago | Grant | 1 | 2.0M | 66032 | 5 months ago | |
|
|
|
Spur Therapeutics | - | Toward the next generation of gene therapy. | Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechno... | - |
United Kingdom
|
Stevenage | United Kingdom (HQ) + 2 | 2015 | Biopharma, Biotechnology +3 | [email protected] |
1
Low
|
122
|
2.4K (-8%) | 3 years ago | Post Ipo Equity | 7 | 302.1M | 11417 | 5 months ago | |
|
|
|
SMi Systems | - | Transformational single-molecule detection and quantification for biomedical res... | SMi is an innovative life science technology company revolutionising molecular s... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) + 1 | 2018 | Biopharma, Manufacturing | - |
1
Low
|
19
|
878 (9%) | 1 year ago | Seed | 3 | 10.6M | 824 | 5 months ago | |
|
|
|
Signatur Biosciences | - | Making precision diagnostics accessible. | Signatur Biosciences makes precision diagnostics more accessible, starting by br... | - |
United Kingdom
|
London | United Kingdom (HQ) | 2022 | Biopharma, Biotechnology | - |
1
Low
|
11
|
285 (-100%) | 2 years ago | Pre Seed | 1 | 500.0K | 829 | 6 months ago | |
|
|
|
Akari Therapeutics, Plc | - | Developing novel advanced therapies to address unmet needs of patients with auto... | Akari Therapeutics, Plc (Nasdaq: AKTX) is a biotechnology company developing adv... | - |
United Kingdom
|
London | United Kingdom (HQ) + 1 | 2015 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
15
|
3.1K (-3%) | 1 year ago | Post Ipo Equity | 5 | 114.3M | 3416 | 1 year ago | |
|
|
|
Sano Genetics | - | Accelerating the world's transition to precision medicine. | At Sano, our mission is to accelerate the world's transition to precision medici... | - |
United Kingdom
|
Cambridge | United Kingdom (HQ) | 2016 | Biopharma, Biotechnology +2 | - |
1
Low
|
82
|
23.0K (-14%) | 11 months ago | Non Equity Assistance | 9 | 20.7M | 8687 | 5 months ago | |
|
|
|
AlgaeCytes | - | Harnessing the potential of microalgae to provide a new generation of health and... | AlgaeCytes is focused on the production of Omega 3 oils and other bio actives fr... | - |
United Kingdom
|
Sandwich | United Kingdom (HQ) | 2010 | Biopharma, Biotechnology +2 | [email protected] |
1
Low
|
14
|
784 (-100%) | 3 years ago | Grant | 3 | 16.0M | 1312 | 7 months ago | |
|
|
|
Adaptimmune | - | Designing and delivering cell therapies to transform the lives of people with ca... |
Adaptimmune is a fully integrated cell therapy company, designed and built from... |
- |
United Kingdom
|
Abingdon | United Kingdom (HQ) + 2 | 2008 | Biopharma, Biotechnology +1 | [email protected] |
1
Low
|
535
|
28.5K (154%) | 1 year ago | Post Ipo Debt | 9 | 499.5M | 50708 | 10 months ago | |
|
|
|
EnsiliTech | - | Creating biologicals without refrigeration. | Our novel ensilication technology exploits the growth of protective silica nanos... | - |
United Kingdom
|
Bristol | United Kingdom (HQ) | 2022 | Biopharma, Pharmaceutical | [email protected] |
1
Low
|
14
|
170 (-60%) | 2 years ago | Pre Seed | 2 | 1.2M | 849 | 5 months ago |